Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2133PDF: 1697HTML: 378 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2806PDF: 1009HTML: 5520 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3371PDF: 1280HTML: 2215Fi.1 Gritti.Rambaldi: 205 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3537PDF: 1182HTML: 4998Incidence age-standardized rates for HL across the Mediterranean basin: 203 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2050PDF: 1868HTML: 348 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3308PDF: 2270HTML: 23330Untitled: 203Untitled: 217Untitled: 231 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3224PDF: 1435HTML: 5848Fig1-Ag-Pil: 226Ag-Pil Fig.2: 228 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7975PDF: 4145HTML: 7370 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1535PDF: 947HTML: 223 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3970PDF: 1301HTML: 2262 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1381HTML: 438PDF: 822 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4107PDF: 1653HTML: 958 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4429PDF: 1639HTML: 3678Tables and Images: 221 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2508PDF: 840HTML: 8880Efremov 1: 227Efremov 2: 191 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1247PDF: 998HTML: 211 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3998PDF: 1054HTML: 3593Untitled: 177Cneo. Fig.1: 114Untitled: 105Untitled: 126Untitled: 133 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7520PDF: 2422HTML: 1733Table 1.: 208Table 2.: 217Table 3.: 202Table 4.: 200 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3323PDF: 1966HTML: 7474 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2560PDF: 967HTML: 15110 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2251PDF: 885HTML: 2001Fig 1 Rossi: 177 -
EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF PEDIATRIC COVID-19 IN THE TERTIARY CARE SYSTEM IN THAILAND: COMPARATIVE DELTA AND PRE-DELTA ERA Pediatric COVID-19 in Thailand during pre-Delta and Delta era
1062PDF: 587HTML: 219 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2171PDF: 1588HTML: 294 -
-
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9078PDF: 6061HTML: 87959Fig.1b: 185Fig.1c: 190Fig.2a: 177Fig.2b: 177Fig.4: 188Fig.2c: 185Fig.3: 182Tab.1: 228Tab.2: 207Tab.3: 190Tab.4: 222Fig1a: 186 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1619PDF: 809HTML: 166 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3068PDF: 878HTML: 7164Kost Fig1: 184Kost Fig 2: 180Kost Fig3: 177Kost Fig 4: 191Kost Fig5: 186Kost fig 6: 174 -
-
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1760PDF: 878HTML: 375Fig1: 233Fig.2: 253Fig. 3: 182Fig. 5: 195Fig. 4: 223 -
-
BIOLOGY OF HUMAN MALARIA PLASMODIA INCLUDING PLASMODIUM KNOWLESI
5283PDF: 2570HTML: 30201Antinori Tables 1,2,3: 348 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1538PDF: 541HTML: 273 -
PEDIATRIC TUBERCULOSIS IN THE NORTH SARDINIA
2460PDF: 856HTML: 2387







